- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0024549

About Theta Pharmaceuticals Limited
Data last updated:
Theta Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Theta Labs Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2002PLC136652. Its GSTIN is 27AAKCS3247G2Z6 (Maharashtra). The company holds 8 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹3.55 Cr. It is led by directors including Meena Agrawal and Shyam Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 621 Hubtown Solaris N. S. Phadke Marg Sai Wadi Andheri East, Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.18 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹6.35 Cr (net margin 122.5%) and EBITDA of -₹2.97 Cr (EBITDA margin -57.4%). Revenue has declined at a compounded annual rate (CAGR) of 61% over three years and 24% over five years.
The company has about 75 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Syncom Healthcare. As per MCA filings, the company has open charges of ₹14.6 Cr and satisfied charges of ₹36.35 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 119 deals on record (118 market trades, 1 ipo); the latest was in June 2021. The company has 10 MSME Form 1 returns on record between 2017 and 2023, listing 122 overdue payments to 25 micro and small suppliers.
Theta Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0024549). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website syncomhealthcare.com.
Company details
CIN history
Theta Pharmaceuticals has one previous CIN (Corporate Identification Number): L51397MH2002PLC136652. The current CIN is U51397MH2002PLC136652, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397MH2002PLC136652 | Current |
| L51397MH2002PLC136652 | Previous |
Recognitions & Rankings of Theta Pharmaceuticals
Contact details
Theta Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Registered AddressUnit No. 621 Hubtown Solaris N. S. Phadke Marg Sai Wadi Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Theta Pharmaceuticals operates one associated brand: Syncom Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Handmade sandwiches, platters, and lunch items are supplied. | syncomhealthcare.com |
Business activity
The main business activity of Theta Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Theta Pharmaceuticals Limited, buy the company report.
Financials of Theta Pharmaceuticals Limited
FY 2025 filings availableTheta Pharmaceuticals Limited reported revenue of ₹5.18 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 8% fall in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -57.4% | ||||
| Net Profit Margin | 122.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Theta Pharmaceuticals Limited, buy the company report.
Board of directors of Theta Pharmaceuticals Limited
Theta Pharmaceuticals has 4 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Agrawal Also directs: Mediworld Hospital and Health Care Consultants LLP, Theta Foods LLP, Gamma Parenterals LLP and 3 more | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Shyam Gupta | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Bharat Agrawal Also directs: Mediworld Hospital and Health Care Consultants LLP, Theta Foods LLP, Gamma Parenterals LLP and 3 more | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Nabh Agrawal | Director | 09 Aug 2024 | 2 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Dec 2021 | 100522596 | Others | ₹14.6 Cr | Open | |
| 31 Jul 2023 | 100812904 | Hdfc Bank Limited | ₹11 Cr | Satisfied | |
| 29 Sep 2006 | 10026482 | Bank of India | ₹35 Lakh | Satisfied | |
| 09 Dec 2005 | 80028452 | Bank of India | ₹25 Cr | Satisfied |
To see the full charge records of Theta Pharmaceuticals Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Theta Pharmaceuticals Limited has 119 deals on record (118 market trades, 1 ipo); the latest was in June 2021.
Deals on record (5 of 119)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Market trade | ₹30.3 Lakh | Buyer: Alpha Leon Enterprises LLP Seller: V L S Finance Limited |
| Dec 2020 | Market trade | ₹5.1 Lakh | Seller: Arcadia Share and Stock Brokers Private Limited |
| Jul 2020 | Market trade | ₹8.3 Lakh | Seller: Alpha Leon Enterprises LLP |
| Jul 2020 | Market trade | ₹21.7 Lakh | Buyer: Alpha Leon Enterprises LLP Seller: 2 individuals |
| Jul 2020 | Market trade | ₹8.6 Lakh | Seller: Alpha Leon Enterprises LLP |
To see the full deal history of Theta Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Theta Pharmaceuticals Limited has 3 court cases on record: 2 filed by Theta Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (M Ex) | Filed against the company by Psychotropic India Ltd | Disposed |
| District court, Indore, Madhya Pradesh | Court case (SC NIA) | Filed by the company against an individual | Disposed |
| District court, Indore, Madhya Pradesh | Court case (SC NIA) | Filed by the company against an individual | Disposed |
To see the full case history of Theta Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Theta Pharmaceuticals Limited has 10 MSME Form 1 returns on record between 2017 and 2023, listing 122 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 25)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pendo Plast Private Limited | |||
| Siddhi Foils | |||
| an individual supplier | |||
| an individual supplier | |||
| Sain Packaging Private Limited |
To see the full MSME payment records of Theta Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Theta Pharmaceuticals has 8 GST registrations: 3 active and 5 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCS3247G2Z6 | Maharashtra | Active | 24 Nov 2017 |
| 27AAKCS3247G3Z5 | Maharashtra | Active | 12 May 2020 |
| 05AAKCS3247G2ZC | Uttarakhand | Active | 16 May 2020 |
To see the full GST registrations and return filing status of Theta Pharmaceuticals Limited, buy the company report.
Recent activity
Theta Pharmaceuticals Limited has 25 board changes on record since 2008: 4 appointments and 21 cessations. The latest: Amit Chandrakant Satardekar ceased to be CFO on 30 Aug 2025.
25 earlier events are in the company report.
Frequently asked questions
Theta Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2002 (24+ years old) and is registered under CIN U51397MH2002PLC136652.
Theta Pharmaceuticals has 4 current directors:
- Meena Agrawal - Director
- Shyam Gupta - Director
- Bharat Agrawal - Director
- Nabh Agrawal - Director
The latest financial statements of Theta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Theta Pharmaceuticals is 27AAKCS3247G2Z6, registered in Maharashtra. The company has 8 GST registrations in all, of which 3 are active and 5 are cancelled or inactive. Other active GSTINs include 27AAKCS3247G3Z5 (Maharashtra), 05AAKCS3247G2ZC (Uttarakhand).
The CIN (Corporate Identification Number) of Theta Pharmaceuticals is U51397MH2002PLC136652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Theta Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it.
Theta Pharmaceuticals was incorporated on 29 July 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
Theta Pharmaceuticals has 119 deals on record (118 market trades, 1 ipo); the latest was in June 2021.
Amit Chandrakant Satardekar ceased to be CFO on 30 Aug 2025. Nabh Agrawal ceased to be Additional Director on 29 Sep 2024. Nabh Agrawal was appointed as Director on 09 Aug 2024. Theta Pharmaceuticals has 25 board changes on record in total.
Yes, Theta Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0024549).
Theta Pharmaceuticals has 10 MSME Form 1 returns on record between 2017 and 2023, listing 122 overdue payments to 25 micro and small suppliers. The latest return was filed on 06 May 2023.